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GROUP A POLYSACCHARIDE PRECIPITIN REACTIONS IN
ACUTE STREPTOCOCCOSIS AND RHEUMATIC FEVER*
LOUIS WEINSTEINt
The r6le of the beta-hemolytic Streptococcus in the etiology of rheumatic
fever has attracted considerable attention for the last twenty or more years.
Although epidemiological studies, particularly those indicating a high inci-
dence of streptococcic pharyngitis preceding first attacks or recurrences of
rheumatic disease., have furnished highly suggestive evidence of the import-
ance of this organism in the pathogenesis of this disorder, the exact mechan-
isms involved have not yet been elucidated. The development of a hyper-
sensitivity reaction to Streptococcus pyogenes or to some of its endo- or
extracellular products has been suggested by many investigators mainly on
the basis of two observations: (i) the presence of a "latent period" between
the initial streptococcal infection and the subsequent development of rheu-
matic fever, and (ii) the appearance of various antibodies to the Strepto-
coccus and its products with greater frequency, in higher concentration,
and persisting for a longer time in the rheumatic state than in uncomplicated
streptococcosis.
A large number of studies of specific and non-specific serologic reactions
have been carried out in an attempt to characterize the immunological reac-
tive pattern of the rheumatic and to contrast it with uncomplicated strepto-
coccal infection in order to detect differences that might be of help in
unmasking the mechanisms involved or in establishing the early diagnosis
of the rheumatic state. Investigations of the serum content of anti-strepto-
lysin, anti-streptokinase, anti-M, anti-C, anti-hyaluronidase, anti-X, anti-
trypsin, C-reactive protein, beta-hemolytic streptococcal agglutinin and
bactericidal antibody, among others, have been thought to indicate that
some of these appear more frequently, are present in larger quantities, and
persist longer in patients with rheumatic fever than in those who have
uncomplicated streptococcosis. None of these studies, however, have suc-
ceeded in attaching an unquestionable direct causal relationship of any of
these immune substances to the pathogenesis of rheumatic fever. Careful
evaluation of the voluminous literature on this subject, which cannot be
reviewed in this paper because of limitations of space, permits only one
conclusion-positive reactions with the various antibodies mentioned above
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indicate no more than recent experience with the beta-hemolytic Strepto-
coccus. Although it has been suggested that their presence in larger num-
bers of patients, their higher titers, and longer persistence can be explained
on a greater degree of immunological reactivity of the rheumatic subject,
this still remains to be proved.
The purpose of this paper is to report the results of a search for antibody
to one of the endocellular materials of the Streptococcus, the group specific
carbohydrate or C substance, in the serums of patients with scarlet fever,
rheumatic fever, and a number of unrelated infections in order to determine
its possible importance in the pathogenesis of rheumatic fever, and to
evaluate its significance in the diagnosis of this disease.
Most of the investigations of the incidence and significance of antibody
to specific streptococcal polysaccharide have been carried out in cases of
rheumatoid and other types of arthritis. Using crude preparations of this
carbohydrate, Dawson and his co-workers' reported a much higher inci-
dence of positive reactions with the serums of rheumatoid arthritics than
with those of individuals who had scarlet fever, glomerular nephritis, osteo-
arthritis, hypertension, diabetes mellitus, bacteremia due to a non-hemolytic
Streptococcus, and "non-articular rheumatism." Bruce and Caswell' em-
ployed crude hydrochloric acid extracts of the beta-hemolytic Streptococcus
and found that 68.7 per cent of a group who suffered from rheumatoid
arthritis had anti-C antibody in their blood, while 13 patients with osteo-
myelitis and 10 normal people did not. A more extensive investigation of
this problem was carried out by McEwen, Bunim, and Alexander8 who used
crude extracts made from the N Y 5 strain of Strep. pyogenes. The per-
centage of positive precipitin reactions noted in various diseases was as
follows: Normal people-24; hemolytic streptococcal disease-62; active
rheumatic fever with carditis and chorea-55; rheumatic fever with poly-
arthritis-56; active rheumatoid arthritis-77; gonococcal arthritis-32;
non-specific, low grade, pyogenic arthritis-31; osteoarthritis-18; gout
and tuberculous spondylitis-12; unclassified, infectious arthritis-46; and
wholly unclassified arthritis-58. Although the incidence of precipitating
antibody for crude extracts of the beta-hemolytic Streptococcus was some-
what higher in patients with rheumatoid arthritis than in those who did
not have this disease, the differences do not appear to be of significant
proportion. About half of a group of rheumatoid arthritics was found by
Neil and Hartung to have antibody for a combination of M and C sub-
stances, while normal individuals or those with osteoarthritis rarely or never
exhibited this precipitin.
Two important studies of the presence of antibody to various of the group
specific carbohydrates of Strep. pyogenes are those of Dawson and
Olmstead5 and Chassis and McEwen.2 These investigators carried out a
search for precipitins to the polysaccharides of groups A, B, C, D, E, F,
and G Streptococcus. They found that a very high percentage of patients
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with rheumatoid arthritis gave positive reactions with group A extracts,
but that the number decreased with the other carbohydrates studied, being
lowest with E, F, and G. Precipitation was observed with normal sera only
occasionally when the A substance was used.
Reports of the presence of precipitin for specific streptococcal carbohy-
drate in rheumatic fever and acute streptococcal pharyngitis are few and
controversial. This antibody could not be detected by Coburn and Pauli'
in a large number of individuals with rheumatic fever. Seegal and his co-
workers11 found the highest incidence of positive anti-C reactions in cases of
rheumatoid arthritis but demonstrated them also in about 45 per cent of
patients with acute hemolytic streptococcal infections, in one-third of those
with endocarditis due to Strep. viridans, and in 12 per cent of acute
glomerular nephritides. Studies of normal controls and of people with non-
infectious diseases revealed this precipitin in from zero to 10 per cent. In
a small group of cases of rheumatic fever, Chassis and McEwen' detected
positive reactions with group A polysaccharide in 100 per cent; in 8
patients with scarlet fever only 25 per cent exhibited this antibody. The
most recent study of this subject is that of Rantz and Randall'0 who reported
that about 8 per cent of people suffering Group A hemolytic streptococcal
infections developed precipitating antibody for the specific polysaccharide
during the course of their illness. The immune response was usually maxi-
mal by the end of the fourth week; no relationship could be established
between it and "the nature of the initial illness" or the development of
suppurative complications. In patients in whom arthritis appeared late in
the course of the disease anti-C precipitins were demonstrable frequently,
either initially or during convalescence, but in those with late fever, they
never appeared. When carditis supervened late in the course of the disease,
about 6 per cent of those who had no detectable antibody at the start of
their illness developed it during recovery.
The studies reported in this paper indicate that precipitating antibody for
the group-specific carbohydrate of Group A Streptococcus pyogenes is
detectable with no greater frequency in patients with rheumatic fever than
in those who have uncomplicated streptococcal pharyngitis. As a matter of
fact, this precipitin is present so often in many unrelated infections that it
appears to have little or no significance even in detecting recent infection
with the beta-hemolytic Streptococcus.
MATERIALS AND METHODS
Five hundred and thirty-seven patients admitted to the Haynes Memorial Hospital
for the treatment of a large variety of infectious diseases were the subjects of this
study. Cultures of the nose and throat were made in every case on the day of admission
and on the following day. All of the streptococci isolated were subjected to grouping
and typing. Ten milliliters of blood were withdrawn aseptically from each person at
the time of admission and again on the fourteenth day, wherever possible. In those
with known streptococcal infections, blood was obtained on the day of entry to the
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hospital, 14 days later, and at the time of discharge. After clotting, the serum was
removed and stored in the deep freeze refrigerator until tested.
The group specific polysaccharide was prepared in the following manner. A strain of
Streptococcus pyogenes, Group A Type 3, which had been frequently passed into mice
in order to maintain a high degree of virulence, was the source of the carbohydrate
used in this study. The bacteria from 30 liters of heart-infusion-yeast-tryptose broth
were obtained by centrifugation after 18 hours of incubation at 370 C. They were
suspended in 200 ml. of N/20 HCl and heated for 10 minutes in a boiling water bath.
Extraction in hydrochloric acid was repeated six times and the extracts pooled. After
clearing by centrifugation, the combined extracts were neutralized with Ni NaOH.
The precipitate which formed was discarded and to the supernatant were added 20
gms. of sodium acetate per liter and 3-4 volumes of 95 per cent ethyl alcohol. Most of
the type-specific nucleoprotein (M substance) has been shown to be precipitated by
this procedure and the polysaccharide to be left in solution, according to Lancefield.6
The supernatant fluid was concentrated to a small volume in vacuo at a temperature
not exceeding 37° C. and the salts dissolved in distilled water. Three volumes of alcohol
were added, the solution placed at ice box temperature overnight and the precipitate
then removed by centrifugation. The supernatant was again concentrated to a small
volume in vacuo at a temperature not above 37° C. This material was dialyzed through
a parchment bag because Lancefield had found that the group specific polysaccharide
was dialyzable through parchment but not through special collodion membranes. Advan-
tage of this phenomenon was taken in order to shorten the process of purification
previously described by Lancefield.7 Dialysis was set up in a closed system against
distilled water and allowed to proceed for twenty-four hours in the ice box. The
dialysate was removed and the procedure repeated five times. All of the dialysates
were then pooled and three volumes of ethyl alcohol added. A very small quantity of
precipitate resulted. After centrifugation, the supernatant was again concentrated in
vacuo to dryness. The material was dissolved in 0.85 per cent NaCl solution. Examina-
tion for the presence of Type 3 M substance and Group A polysaccharide, using potent
specific antisera, revealed complete absence of the type specific nucleoprotein and large
quantities of carbohydrate A. This solution, diluted to the point where it gave 4 plus
reactions with potent anti-Group A serum after 2 hours of incubation at 370 C. and
24 hours' storage in the ice box, was the one used in performing all of the precipitin
tests reported in this paper. All of the tests were set up in duplicate and all, whether
positive or negative, were repeated twice.
The following'method was used to detect the presence of precipitating antibody for
the purified Group A carbohydrate. The C-containing solution was layered over the
patient's serum in a capillary precipitin tube and incubated at 370 C. for two hours.
After 24 hours' storage in the ice box all the tubes were examined for precipitation
and again placed at low temperature. Readings were made again after 48 and 72 hours
of ice box storage. For every test, a control consisting of the bacterial extract plus
saline and of the patient's serum plus saline was set up. The results were not recorded
in terms of degree of precipitation but only as positive or negative.
RESULTS
Streptococcal Infections
One hundred twenty patients with scarlet fever were studied. The serum
of 40 (33.3 per cent) showed precipitation when mixed with the purified
group-specific polysaccharide. Seventy-five per cent of these had C-
precipitin at the time of admission to the hospital but in the remainder,
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this antibody was absent in the initially drawn serum but was present 14
days later. There appeared to be no correlation between age of the patients,
the severity of the disease, the persistence of streptococci in the pharynx,
and the development of suppurative or non-suppurative complications, and
the appearance of anti-polysaccharide precipitins.
Seven cases of erysipelas were examined; none of them developed
antibody for the C substance. Of 24 individuals with suppurative otitis
media due to Streptococcus pyogenes, 12 (50 per cent) exhibited the
presence of carbohydrate precipitin two weeks after admission to the hos-
pital. In none of them was there any relation between severity and compli-
cations of the primary disease and the development of this immune reaction.
Seventy-six patients with acute rheumatic fever were studied. All of them
had obvious clinical rheumatic disease; those with questionable syndromes
were excluded from the investigation. The precipitin reaction was positive
in only 18 (23.7 per cent). In every instance in which this antibody was
detected it was present at the time of admission to the hospital. None of
those which were initially negative subsequently became positive. There
was no relation between the presence or degree of severity of carditis or
arthritis or the duration of rheumatic activity and the development of
polysaccharide precipitin.
Only six cases of acute glomerulonephritis were available for study. Of
these, three (50 per cent) gave a positive reaction for streptococcal group
specific polysaccharide at the time of admission to the hospital; in the
others, this antibody was not detectable even late in the course of the
disease.
The results obtained indicate that the development of precipitating
antibody for purified group A specific polysaccharide of the beta-hemolytic
Streptococcus does not take place in every patient infected by this organism.
There also does not seem to be any relation between severity of the pri-
mary streptococcal disease or of its complications and the frequency with
which this type of immune reaction appears. It is quite striking that in
erysipelas this precipitin was never detected; this observation must be
qualified, however, by the fact that only a few patients with this disease
were studied. Most interesting is the demonstration of a somewhat lower
incidence of positive reactions in patients with frank rheumatic fever than
in those who had streptococcic pharyngitis without developing this compli-
cation. Although the frequency of positive reactions in acute glomerulo-
nephritis was somewhat higher than in scarlet or rheumatic fever, this may
be accounted for by the relatively small number of cases examined.
These data suggest that the development of antibody to the group-specific
carbohydrate of the Streptococcus is without significance either in the
diagnosis of Streptococcosis (this point is further emphasized by the results
presented below) or in the pathogenesis of rheumatic fever or glomerulo-
nephritis. Absence of this precipitin does not rule out the presence of
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streptococcic infection, since at least two-thirds of the patients with scarlet
fever never developed it even during the course of persistent streptococcic
infection despite the fact that some of them exhibited suppurative
complications due to Strep. pyogenes.
Infections Other Than Those Due to the Streptococcus
In order to evaluate the importance of the presence of precipitin for
group A polysaccharide in the blood of patients with infections due to
Streptococcus pyogenes, the serum of 304 individuals with illnesses due to
TABLE 1
INCIDENCE OF PRECIPITIN REACTIONS WITH GROUP A POLYSACCHARIDE IN
VARIOUS STREPTOCOCCAL AND OTHER DISEASES
Per cent positive
No. of No. of positive precipitin
Disease patients precipitin reactions reactions
Scarlet fever 120 40 33.3
Strep. otitis media 24 12 50.
Erysipelas 7 0 0.
Acute rheumatic fever 76 18 23.7
Glomerulonephritis 6 3 50.
Diphtheria carriers 3 3 100.
Acute diphtheria 42 5 11.9
Scabies 61 25 41.
Syphilis 42 7 16.7
Rubella 3 1 33.3
Varicella 20 3 15.
25 other diseases 133 0 0.
other bacteria, viruses, and other parasites were examined. The diseases
studied and the number of patients (in parentheses) in each group were as
follows: Bacterial infections-pertussis (17), pulmonary tuberculosis (15),
diphtheria (42 active cases and 3 asymptomatic carriers); meningitis (5),
suppurative otitis media (3), and tracheitis (2) due to H. influenzae:
meningitis due to Ps. aeruginosa (3), meningococci meningitis (2), gonor-
rhoea (2), staphylococcal osteomyelitis and bacteremia (1), tracheitis due
to Strep. viridans (1), bronchopneumonia due to various organisms includ-
ing D. pneumoniae (5), and fusospirochetal angina (2). Virus infections-
measles (28), varicella (20), mumps (7), infectious mononucleosis (6),
rubella (3), viral diarrhea of infants (2), probable viral pharyngitis (19),
viral tracheitis (1), and infectious hepatitis (1). Miscellaneous infections
and other diseases-scabies (61), secondary and tertiary syphilis (42),
monilial stomatitis (2), cervical adenopathy of unknown etiology (2),
dermatitis (3), appendicitis (1), and scurvy (1).
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Precipitin for group A specific carbohydrate of the beta-hemolytic
Streptococcus was demonstrable only in the following diseases: diphtheria,
varicella, rubella, scabies, syphilis, and in the asymptomatic diphtheria
carrier state. The antibody was present most frequently in diphtheria
carriers-100 per cent; the significance of this is difficult to evaluate, how-
ever, since only three cases were investigated. In 61 individuals with scabies,
25 or 41 per cent gave positive reactions. Fifteen per cent of the instances
of varicella, 33.3 per cent of those with rubella, 14.9 per cent of the
syphilitics, and 12.5 per cent of the patients with active diphtheritic pharyn-
gitis yielded precipitins for the C substance. The remaining 133 persons
suffered from 25 different disease processes, mostly various infections.
Specific streptococcal carbohydrate precipitin was not detected in any mem-
bers of this group. The results of the entire study are presented in Table 1.
DISCUSSION
Many of the investigations that have been carried out in an attempt to
demonstrate precipitating antibodies for the group specific polysaccharide
of Group A beta-hemolytic Streptococcus have been somewhat confused by
the use of crude preparations which contained not only the carbohydrate,
but also type specific nucleoprotein M and the non-specific nucleoprotein P.
The data presented in this paper were obtained with highly purified strepto-
coccal polysaccharide. Advantage was taken of Lancefield's observation7 that
the group specific substance is dialyzable through ordinary parchment
membranes. The method of purifying the material which was used in the
present study was thus made more simple while the degree of purity was
increased at the same time. As was pointed out above, the preparation
employed was entirely free of the type-specific nucleoprotein as shown by
its failure to be precipitated by potent Type 3 specific antiserum.
The results obtained in various types of streptococcal disease are some-
what at variance with other published reports. Unlike the studies of Coburn
and Pauli8 who could not demonstrate precipitin for streptococcal carbo-
hydrate in the serums of patients with pharyngitis or rheumatic fever, or
those of Chassis and McEwen' who found this antibody in 100 per cent of
rheumatics, the present investigation revealed that about one-third of cases
of scarlet fever and about one-fourth of those with rheumatic fever had posi-
tive reactions. The data of Rantz and Randall'0 suggest a lower incidence
of anti-C antibody-8 per cent in Group A hemolytic streptococcal infec-
tions. The failure to detect the C-precipitin in seven cases of erysipelas
cannot be explained. The observations demonstrating a lack of relationship
between the severity of the initial disease or the appearance of suppurative
complications and the development of the immune reaction are in accord
with those of Rantz and Randall.'0
Most striking is the fact that not all of the patients with proved strepto-
coccal infections exhibited precipitating antibody for the group-specific
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carbohydrate. This may be due to the relatively poor antigenicity of the
polysaccharide even in its natural state in the organism. It is well known
that injection of whole streptococci into experimental animals leads to the
development of active C-precipitins. The rate of response may be slow,
however, and many repeated injections of large numbers of streptococci may
be necessary before detectable antibody can be demonstrated. It is of con-
siderable significance that cases of scarlet fever appeared to produce carbo-
hydrates precipitin with somewhat greater frequency than those who had
rheumatic fever. This tends to minimize consideration of the role of sensi-
tization to group-specific streptococcal polysaccharide as a possible mechan-
ism in the development of the rheumatic state. Since this antibody appeared
in only about one-third of the cases of bacteriologically proved streptococcal
pharyngitis, failure to detect its presence obviously does not eliminate
the possibility that an individual has had recent experience with the
Streptococcus.
The demonstration of a relatively high incidence of carbohydrate-
precipitating antibody in a number of infectious diseases produced by agents
completely unrelated, so far as is known, to the beta-hemolytic Strepto-
coccus is interesting and important. The frequent occurrence (41 per cent)
of this precipitin in scabies and its demonstration in 15 per cent of indi-
viduals with syphilis or chicken pox raises some interesting problems. It is
entirely possible that the patients with these diseases who exhibited this
antibody had also had a recent streptococcal infection, although no evidence
of this was present at the time they were studied. If the anti-C precipitin
persists in the blood for a long time, its presence in individuals with scabies,
for example, might be explained on the ground of streptococcic invasion
months or years prior to the present examination. The possibility that
Sarcoptes scabei may possess a polysaccharide similar or closely related to
that of Strep. pyogenes also merits some consideration, although there is no
evidence in support of such a speculation. The demonstration of carbohy-
drate precipitating antibody in the blood of patients, without clinical or
laboratory evidence of recent experience with the beta-hemolytic Strepto-
coccus, cannot be used to prove or disprove the diagnosis of acute
streptococcosis or rheumatic fever.
CONCLUSIONS
1. A modified method for the purification of the group-specific poly-
saccharide of Group A Streptococcus is described.
2. The incidence of precipitin for streptococcal carbohydrate is
somewhat lower in rheumatic fever than in uncomplicated streptococcal
pharyngitis.
3. Only about one-third of patients with bacteriologically proved scarlet
fever develop anti-polysaccharide antibody.
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4. Precipitating antibody for streptococcal carbohydrate is frequently
demonstrable in the absence of streptococcic infection.
5. Absence of anti-C antibody does not rule out the presence of active
streptococcic disease or rheumatic fever.
6. Hypersensitization to group-specific polysaccharide is of no signifi-
cance in the pathogenesis of the rheumatic state.
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